Breast Implant Illness: DNA, Genes, and Uncovering the Hidden Story! #shorts
29 May 2026 · 0 min

0:04
In this short interview, Dr. Robert Whitfield MD explains the latest DNA‑based findings related to breast implant illness (BII). He references earlier work on urine inflammation markers and then highlights the major breakthrough from Dr. Mansour’s functional genomics group, which has generated over 200 patient genetic reports. By examining patterns of poorly functioning genetic pathways together with environmental exposures, Dr. Whitfield identifies four recurrent pathways that appear dysregulated in BII patients: immunity, vitamin‑D metabolism, methylation, and the glutathione/antioxidant system. He emphasizes that recognizing these genetic‑environmental patterns allows clinicians to ‘read’ the disease story directly from the data.










